FIELD: medicine.
SUBSTANCE: present invention relates to a carrier for delivering a substance into extracellular matrix producing cells in the kidney, wherein the carrier contains a retinoid as a targeting agent. Present invention also relates to an agent for treating renal fibrosis caused by diabetic nephritis and reducing fibrosis in the mesangial region and surrounding tubular cells, wherein said carrier is used. Present invention also relates to methods for preparing a carrier and an agent, sets for preparing and a method and the like for treating renal fibrosis using an agent for treating renal fibrosis.
EFFECT: disclosed is an agent for treating renal fibrosis.
10 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR KIDNEY FIBROSIS TREATMENT | 2011 |
|
RU2635460C2 |
| AGENT FOR TREATING MYELOFIBROSIS | 2009 |
|
RU2557997C2 |
| COMPOSITION FOR RECOVERY OF NORMAL TISSUE FROM FIBROUS TISSUE | 2011 |
|
RU2650796C2 |
| THERAPEUTIC AGENT APPLICABLE IN PULMONARY FIBROSIS | 2009 |
|
RU2547571C2 |
| MEANS FOR INTESTINAL FIBROSIS TREATMENT | 2012 |
|
RU2637372C2 |
| THERAPEUTIC AGENT FOR PULMONARY FIBROSIS | 2015 |
|
RU2678968C2 |
| LIPOSOMS WITH RETYNOID TO STRENGTHEN hsp47 EXPRESSION MODULATION | 2012 |
|
RU2628694C2 |
| COMPOUNDS FOR TARGETED DRUG DELIVERY AND ENHANCING siRNA ACTIVITY | 2012 |
|
RU2769872C2 |
| COMPOUNDS FOR TARGETED DELIVERY OF MEDICINE AND ENHANCED SIPHK ACTIVITY | 2012 |
|
RU2632888C2 |
| THERAPEUTIC COMPOSITIONS AND METHODS AGAINST MALIGNANT TUMORS WITH RNAi MOLECULES DIRECTED AGAINST Hsp47 | 2015 |
|
RU2756253C2 |
